NUPLAZID: payments to doctors
Payments that named NUPLAZID as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $18.8M
- Providers
- 19,328
- Transactions
- 136,226
- Average per transaction
- $138
The per-transaction average — $138 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 19,328 providers the average total is $975, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Acadia Pharmaceuticals Inc | $18,842,427 | 100.0% |